Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes

ClinicalTrials.gov ID: NCT06326047

Public ClinicalTrials.gov record NCT06326047. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 8:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Investigation of the Safety and Efficacy of Once Weekly NNC0519-0130 in Participants With Type 2 Diabetes - a Dose Finding Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will look at how well a new medicine called NNC0519-0130 helps people with type 2 diabetes lower their blood sugar and body weight. The study will test up to 7 different doses of NNC0519-0130. Which treatment participant will get is decided by chance. Participants will take 1-3 injections once a week. The study medicine will be injected under skin with a thin needle in the stomach, thigh, or upper arm. The study will last for about 40 weeks.

Study identification

NCT ID
NCT06326047
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
299 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 17, 2024
Primary completion
Sep 18, 2025
Completion
Oct 12, 2025
Last update posted
Aug 12, 2026

2024 – 2025

United States locations

U.S. sites
55
U.S. states
19
U.S. cities
49
Facility City State ZIP Site status
Velocity Clin Res-Chula Vista Chula Vista California 91911
Valley Research Fresno California 93720
310 Clinical Research Inglewood California 90301
Velocity Clin Res San Diego La Mesa California 91942
First Valley Med Grp Lancaster Lancaster California 93534
Torrance Clin Res Inst, Inc. Lomita California 90717
Pacific Clinical Studies Los Alamitos California 90720
Velocity Clinical Research Westlake Los Angeles California 90057
Catalina Research Institute, LLC Montclair California 91763
Artemis Insitute for Clin Res San Diego California 92123
Med Partners, Inc. Toluca Lake California 91602
UCLA Health Southbay Endocrine Torrance California 90505
University Clin Investigators Tustin California 92780
Diablo Clinical Research, Inc. Walnut Creek California 94598
University of Colorado Hospital Aurora Colorado 80045
Innovative Research of W Florida Inc. Clearwater Florida 33756
Innovative Research of W FL Clearwater Florida 33756
International Research Associates, LLC_Miami Miami Florida 33183
Centricity Research Columbus Georgia 31904
Elite Clinical Trials Blackfoot Idaho 83221
Methodist Medical Center of Illinois Peoria Illinois 61603
University of Iowa Iowa City Iowa 52242
Centennial Medical Group Columbia Maryland 21045
MD Medical Research Oxon Hill Maryland 20745
Endo And Metab Cons Rockville Maryland 20852
Clinvest Research Springfield Missouri 65807
Mercury Str Med Grp, PLLC Butte Montana 59701
Velocity Clinical Research Lincoln Lincoln Nebraska 68510
Excel Clinical Network Las Vegas Nevada 89109
Palm Research Center Inc-Vegas Las Vegas Nevada 89148
Velocity Clinical Research Binghamton Binghamton New York 13905
PharmQuest Life Sciences LLC Greensboro North Carolina 27408
Accellacare Wilmington Wilmington North Carolina 28401
Diab & Endo Assoc of Stark Co Canton Ohio 44718
Velocity Clin Res_Cincinnati Cincinnati Ohio 45242
Velocity Clinical Research Springdale Cincinnati Ohio 45246
Providence Health Partners Ctr Dayton Ohio 45439
Advanced Med Res Maumee Maumee Ohio 43537
Velocity Clin Res Grants Pass Grants Pass Oregon 97527
Tristar Clin Investigations, PC Philadelphia Pennsylvania 19114
Preferred Primary Care Physicians Inc. Pittsburgh Pennsylvania 15243
Preferred Primary Care Physicians, Inc. Uniontown Pennsylvania 15401
Velocity Clinical Research Abilene Abilene Texas 79606
Velocity Clin Res Austin Austin Texas 78759
Velocity Clinical Res-Dallas Dallas Texas 75230
Zenos Clinical research Dallas Texas 75230
UT Southwestern Med Center Dallas Texas 75390
Care United Research, LLC Forney Texas 75126
Endocrine Associates Houston Houston Texas 77004
Biopharma Informatic_Houston Houston Texas 77043
Tekton Research Irving Texas 75039
Epic Clinical Research Lewisville Texas 75057
Consano Clinical Research, LLC Shavano Park Texas 78231
Burke Internal Medicine & Research Burke Virginia 22015
TPMG Clinical Research Newport News Virginia 23606

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 55 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06326047, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 12, 2026 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06326047 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →